What we're reading, November 2, 2016: Donald Trump attacks Obamacare while drug makers pour funding into Republican candidates, and Anthem considers reducing Affordable Care Act participation and is under fire in California for auto-renewals.
Republican candidate Donald Trump has shifted his focus to attacking President Barack Obama’s Affordable Care Act and its rising premiums. According to The Wall Street Journal, Trump is calling to repeal and replace the law as premiums have risen in battleground states. Hillary Clinton has an edge in the state of Pennsylvania, but the state has been hard hit by premium increases, which are up by an average of 50%. Meanwhile, drug companies have been supporting Republican candidates. The pharmaceutical industry expects a fight over drug prices next year, and a Clinton win with Democrats taking over both the House and the Senate is not a scenario drug makers are comfortable with, reported STAT.
A consumer group in California is suing Anthem Blue Cross because it automatically renewed consumers into plans that have reduced coverage. The consumer group claims Anthem was not properly disclosing to consumers that the plans no longer cover out-of-network costs, reported the Los Angeles Times. The consumer group’s lawyer said that Anthem should have sent a discontinuation notice so customers knew they were losing that coverage. Anthem’s financial results may cause it to cease participating in the Affordable Care Act’s exchanges. According to Bloomberg, the company would join UnitedHealth Group, Aetna, and Humana, which have already reduced their involvement due to poor financial performance and losses. Anthem is currently selling coverage in 14 states and if it decides to scale back participation, then it would be for 2018, not next year.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More